Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Nanomerics
Recent news which mentions Nanomerics
Virpax Pharmaceuticals 2022 R&D Expenses Grow 122% To $10.8M, Here Are The Details
March 22, 2023
Tickers
VRPX
Tags
Cannabis
Markets
Market News
From
Benzinga
Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology
February 13, 2023
Tickers
VRPX
Tags
Benzinga
premium
Jeffrey Murray
From
Benzinga
Virpax Receives pre-IND Application Guidance From The FDA For Its CBD-Based Drug Candidate For Epilepsy
December 14, 2022
Tickers
VRPX
Tags
News
Nanomerics
VRPX
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.